Xiangzhen Kong

机构：Fudan University, Shanghai University of Traditional Chinese Medicine, Institut thématique Génétique, génomique et bioinformatique, Yueyang Hospital, Shanghai Traditional Chinese Medicine Hospital

发表论文 24 篇 · 总被引 260 次 · h-index 10

代表论文

Lipid metabolism as a target for cancer drug resistance: progress and prospects (2023 · Frontiers in Pharmacology · 被引 64)
mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer (2024 · Nature Cell Biology · 被引 35)
Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer (2020 · Journal of Cancer · 被引 30)
Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma (2018 · Cell Cycle · 被引 23)
Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing (2018 · Cellular Physiology and Biochemistry · 被引 22)
Rapid extraction and determination of 25 bioactive constituents in Alpinia oxyphylla using microwave extraction with ultra high performance liquid chromatography with tandem mass spectrometry (2015 · Journal of Separation Science · 被引 16)